Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Squamous Cell of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00003139
What this trial is testing

Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOral Complications
Radiation Therapy Oncology Group 249
Testing effectiveness (Phase 2)Study completedNCT05517330
What this trial is testing

Neoadjuvant Tislelizumab With Afatinib for Resectable Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
West China Hospital 23
Early research (Phase 1)Ended earlyNCT01987375
What this trial is testing

Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures

Who this might be right for
Head and Neck Cancer
Eben Rosenthal 1
Testing effectiveness (Phase 2)Study completedNCT03723967
What this trial is testing

FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Centre Leon Berard 104
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07683507
What this trial is testing

Becotatug Vedotin Plus PD-1 Inhibitor for Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Feng Liu 60
Large-scale testing (Phase 3)UnknownNCT00002884
What this trial is testing

Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Centre Hospitalier Lyon Sud 326
Testing effectiveness (Phase 2)Study completedNCT00720304
What this trial is testing

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 43
Testing effectiveness (Phase 2)Looking for participantsNCT07481058
What this trial is testing

KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Beijing Konruns Pharmaceutical Co., Ltd. 60
Not applicableStudy completedNCT01487733
What this trial is testing

Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group 155
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT05527782
What this trial is testing

Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Hospital Universitario Doctor Peset 40
Testing effectiveness (Phase 2)Study completedNCT05516589
What this trial is testing

Neoadjuvant Chemotherapy, Tislelizumab With Afatinib for HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
West China Hospital 40
Not applicableStudy completedNCT04059861
What this trial is testing

Ultrasound in Tongue Cancer- a Help to Decide Depth of Invasion and to Improve the Surgical Margin

Who this might be right for
Tongue CancerFloor of Mouth Squamous Cell Carcinoma
Region Örebro County 42
Testing effectiveness (Phase 2)UnknownNCT05386056
What this trial is testing

Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 54
Early research (Phase 1)Ended earlyNCT04234113
What this trial is testing

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Thyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more
SOTIO Biotech AG 115
Early research (Phase 1)Ended earlyNCT03818542
What this trial is testing

Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
AbbVie 3
Testing effectiveness (Phase 2)Ended earlyNCT01525927
What this trial is testing

Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity

Who this might be right for
Oropharyngeal Neoplasms
Northwell Health 2
Testing effectiveness (Phase 2)Study completedNCT01081041
What this trial is testing

A Study in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Eli Lilly and Company 187
Testing effectiveness (Phase 2)Active Not RecruitingNCT02919683
What this trial is testing

Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)WithdrawnNCT04262388
What this trial is testing

A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck
University Health Network, Toronto
Next Page